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Abstract 
Background: Achieving insulin independence is emerging as a realistic therapeutic goal in the management of 
feline diabetes mellitus.
Case presentation: The management of an 11-year-old spayed female Burmese cat presenting with diabetes mel-
litus after corticosteroid administration is described. Remission was achieved after the frequency of insulin admin-
istration was increased to four times a day, and supported by intensive home blood glucose monitoring and a high 
protein, low carbohydrate diet.
Conclusion: Owners are important collaborators in feline diabetes care and, with intensive home monitoring, more 
frequent insulin treatment may lead to remission without hypoglycemia. More frequent insulin injections than recom-
mended in the literature may be necessary to achieve glycemic control and used as an alternative to a longer-acting 
insulin.
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Background
Feline diabetes mellitus is characterised by insulin resist-
ance and impaired insulin secretion, and its prevalence is 
increasing, partly due to lifestyle factors, including indoor 
confinement and physical inactivity [1–3]. Lean cats with 
low insulin sensitivity are predisposed to impaired glu-
cose tolerance with weight gain [4]. Increasing weight is 
a risk factor for diabetes [1, 3, 5], along with advancing 
age [1, 5, 6] and sex, with diabetes being more common 
in neutered male cats [1, 3, 5, 6]. Burmese cats in the UK 
are 3.7 times more likely to develop diabetes than non-
pedigree cats [3]. Similar observations have been made 
of Burmese cats in Australia [7, 8] and Sweden [9]; and 
recent studies suggest that this is due to dysregulation 
of lipid metabolism in this breed [10, 11]. A recent pilot 
study suggests involvement of a major gene locus in dia-
betes in Burmese cats [12].
Diabetes remission rates exceeding 60  % have been 
reported in cats receiving pharmacological and dietary 
management [13–15], and remission may be achieved 
in cats that have ketoacidosis at presentation [16]. Insu-
lin and diet are the mainstays of therapy. It is reported 
that the remission rate is higher on glargine compared to 
porcine lente insulin [17]. A recent systematic review has 
reported that successful remission rates vary considerably 
and that remission is associated with a variety of insulin 
types and protocols [18]. The duration of insulin action of 
glargine, although reported to be on average longer than 
lente [19], may vary from animal to animal [20]. There 
is an anecdotal report of effective management in two 
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diabetic cats using multiple daily injections of a mixture 
of short acting and long acting insulin [21].
While insulin independence is a realistic therapeutic 
goal in feline diabetes, remission is dependent on achiev-
ing glycemic control quickly [22] and, without intensive 
monitoring, high insulin doses increase the risk of hypo-
glycemia. We present a case of an 11-year old spayed 
Burmese cat that presented with diabetes after steroid 
treatment for skin allergy. Control of blood glucose was 
not achieved using a low carbohydrate diet plus the rec-
ommended twice-daily treatment with either insulin 
lente or glargine, with the total dose limited by the risk 
of hypoglycemia. A more frequent insulin regimen using 
glargine was used successfully.
Case presentation
A five-year-old female neutered Burmese (Swedish and 
UK origin) was started on a management strategy for 
allergic dermatitis consisting of short course of 5  mg 
prednisolone twice daily, rapidly tapering and with-
drawn after 3  weeks. This programme was repeated 
five times over the next 6  years until at 11  years of age 
the cat received a single injection of methylpredniso-
lone (Depo-Medrol 20 mg i.m.) and, within 5 days, was 
observed to have polydipsia and polyuria. Home urinaly-
sis (Keto-Diastix, Bayer) revealed glucose (2+) without 
ketonuria and, at initial veterinary assessment 2  days 
later the cat weighed 3.2  kg (last recorded weight was 
3.5  kg 18  months previously) and had a body condition 
score of 4 (on a 9 point scale [23]) with no other signifi-
cant abnormalities detected on physical examination. 
Routine serum biochemistry revealed marked hyper-
glycemia (blood glucose concentration 29.8  mmol/L 
(reference range 3.9–8.8) and increased fructosamine 
concentrations (481  µmol/L, 190–340). All other meas-
ured parameters were within normal limits. Initial man-
agement consisted of a high protein, low carbohydrate 
diet (Purina DM wet and dry food, fed ad  libitum in a 
ratio of at least 3:1) and twice daily porcine lente insulin 
(Caninsulin, MSD Animal Health), starting with 1 unit 
q12 h, started immediately (on day seven after the injec-
tion of methylprednisolone). Capillary blood monitoring 
from the pinna of the ear was commenced using a blood 
glucose meter calibrated for human blood that is used 
in cats (Accu-Chek Aviva, Roche UK; feline reference 
range 2.8–5.5  mmol/L for meter [14]). Blood glucose 
was taken prior to insulin injection. On some days glu-
cose was also measured more frequently between insulin 
injections; for example every 3 h or when hypoglycaemia 
was suspected). Figure 1 shows all of the results for blood 
glucose testing for the first 4  months of management. 
During the first 7 days of testing the mean glucose value 
was 21  mmol/L. The owner obtained a urine sample, 
which was delivered to the local veterinary practice, and 
which revealed a pure growth of an Enterococcus. Given 
the clinical circumstances, this was suspicious of UTI and 
was treated with antibiotics by the veterinary surgeon.
On day 27, the cat was on porcine lente insulin, 2.5 
units insulin q12 h and glucose curves documented clear 
falls in glucose in response to injections, with a nadir 
at around 4 h (Fig. 2a). It was considered that the short 
duration of insulin action might be a limiting factor in 
achieving good glycemic control and the cat was started 
on glargine, an insulin analogue registered for human 
use. On q12 h glargine (4.5–6.5 units per day; 2–3.5 units 
per injection; Lantus, Sanofi-Aventis) there appeared 
to be no difference in the pattern of glucose responses 
(Fig.  2b), again limiting the total daily dose of insulin 
that could be delivered without an unacceptable risk of 
hypoglycemia. For this reason and, concerned that the 
chance of β cell recovery was diminishing with increas-
ing duration of hyperglycemia, on day 47 a decision was 
made to increase the frequency of glargine injections to 
8-hourly, with a slight increase total daily dose of insulin 
(to 5.5–7 units per day; 1.5–2.5 units per injection). The 
owner performed frequent blood glucose measurements 
at home (Fig. 2c). On day 53 the frequency of injections 
was increased to 6-hourly, with an increase in the total 
dose (to 7–9 units per day; 1.5–3 units per injection) 
(Fig. 2d, e) and the daily insulin dose was tapered (Fig. 3) 
from 2 units q6 h on day 64 to 0.25 units q6 h on day 77. 
Intensive monitoring, often every three hours, on day 
67–70 revealed that the lowest blood glucose value was 
2.7 mmol/L on days 64 and 67. Although only one blood 
glucose value of  <2.8  mmol/L had been recorded, the 
owner-physician interpreted the relative hyperglycemia 
during this period to represent rebound hyperglycaemia, 
and continued to taper the dose of insulin. On day 62 
and 65, the dose of insulin was reduced by 21 and 37 %, 
respectively; the decrease in dose over this time was oth-
erwise not greater than 20 %. On days 77 and 102, blood 
glucose levels of 2.7 and 2.1, respectively were recorded 
and were not followed by hyperglycaemia.
From day 77, when the cat was on a total daily dose of 
1 unit of glargine, glucose concentrations were mostly 
within the reference range. However it seemed that insu-
lin was still required to achieve euglycemia, and that 
requirements to achieve euglycaemia were increasing. On 
day 95, on 0.5 units q6 h glargine, glucose concentrations 
were 6–8  mmol/L and a fructosamine concentration 
was 280  µmol/L, in the middle of the reference range. 
On day 98 it was noted that the weight had increased to 
3.9 kg with a body condition score of 6. The total caloric 
intake was thereafter restricted to a maximum of 75  g 
wet and 25  g dry food (Purina DM) and physical activ-
ity was increased by playing with the cat several times a 
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Fig. 1 Total daily insulin doses (a) and all blood glucose values (b) from commencement of treatment until 1 week after cessation of insulin. The 
shaded area represents the normal blood glucose range. The broken arrow represents the time that caloric intake was restricted to a maximum of 
75 g wet and 25 g dry food (Purina DM) and increased physical activity by encouraging play several times a day. The solid arrow indicates the time 
when insulin was ceased
Fig. 2 Daily blood glucose profiles on porcine lente insulin 12-hourly (a) and glargine 12-hourly (b), 8-hourly (c) and 6-hourly (d, e). Times of insulin 
administration are indicated by the arrows. The day from the start of insulin treatment and total daily units (U) of insulin are indicated to the right of 
each profile
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day. Within 5  days insulin was withdrawn and 1  month 
later, a visit was made to the local veterinary surgeon. The 
fructosamine was 271 µmol/L. Over the following 4 years 
later the cat has remained insulin-independent and, when 
glucose concentrations are measured (occasionally) these 
ranged from 4.6 to 5.1 mmol/L.
Conclusions
This case demonstrates that changing the frequency of 
insulin injections can be considered as an alternative to 
changing to a longer-acting insulin and offered to own-
ers of cats not achieving control on twice daily regimes. 
Hypoglycemia is one of the biggest concerns for owners 
of cats with diabetes [24] and is associated with larger 
doses of insulin [25]. It is possible that the risk of hypo-
glycemia could be avoided by dividing the insulin dosage 
and administering at more frequent intervals. Alterna-
tively some cats may respond to changing to an insulin 
that is longer-acting, for example changing from lente to 
glargine, or from glargine to detemir [26]. These insulins 
may have a shorter duration of action than in humans 
[20]. Detemir has less variability in duration of action 
between cats and in some cats, the duration of action is 
longer than for glargine [20]. The phase of relative hyper-
glycemia observed in this case report was interpreted 
by the owner as representing a significant counter-reg-
ulatory response, even in the absence of documented 
hypoglycemia, and responded by reducing the insulin 
dose. In retrospect, looking at the pattern of blood glu-
cose levels and considering the intensive monitoring, it 
is unlikely that frank hypoglycaemia was responsible for 
the paradoxical increase in blood glucose. An alternative 
explanation is that decreases in insulin dose may have 
contributed to the phenomenon.
The decline in β cell function in feline diabetes is 
believed to be a consequence of glucotoxity, that is ini-
tially reversible but later irreversible [18]. Glucocorticoid 
administration is a well-documented risk factor for feline 
diabetes and may well have contributed to the onset of 
hyperglycemia by decreasing insulin sensitivity in this 
case. Cats treated with corticosteroid in the 6  months 
prior to diabetes diagnosis are more likely to go into 
remission than those that did not receive steroids [14]. In 
this case the product delivered was an insoluble steroid 
ester and hence its effect could well have lasted for up to 
6 weeks. However, once insulin resistance had improved, 
appropriate insulin dosing appeared to be important 
to resolve glucotoxicity for recovery of β cell function. 
Other reported risk factors were also present in this cat, 
including advancing age, indoor confinement and physi-
cal inactivity, and Burmese breed [7–9]. Although diets 
that are low in carbohydrate have an important place in 
management of the disease [13, 27], when fed ad libitum 
they may lead to greater weight gain than diets that are 
relatively high in carbohydrate and low in fat [28], and 
may have contributed to the weight gain in this case 
because they are also high in fat [29].
The owner of this particular case, a physician herself, 
took a great deal of responsibility in day-to-day manage-
ment decisions. A recent feline diabetes-associated qual-
ity of life survey indicated that the areas reported as most 
negatively impacting included “owner wanting more con-
trol” [24]. In humans, interventions that involve patient 
collaboration are particularly important in improving 
Fig. 3 All blood glucose values from day 53 to day 79 of treatment. The shaded area represents the normal blood glucose range. The total daily 
glargine dose, that was divided and delivered 6-hourly, is shown
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self-care behaviours, quality of life and empowerment, to 
such an extent that the International Diabetes Federation 
has deemed that diabetes self-management education is 
considered a right for all those with, or at risk of, diabetes 
[30]. It is similarly recommended that owners of cats with 
diabetes should be informed of the options available to 
them, including the benefits of tight glucose control and 
home capillary glucose monitoring.
Authors’ contributions
ML was involved in the clinical handling of this case and drafted the manu-
script. ES was involved in discussion regarding the clinical handling of the 
case. All authors contributed to critically revise the manuscript and gave final 
approval. All authors read and approved the final manuscript.
Author details
1 School of Health, Nursing and Midwifery, University of the West of Scotland, 
Paisley, Scotland, UK. 2 Department of Clinical Sciences, Swedish University 
of Agricultural Sciences, Uppsala, Sweden. 3 Department of Veterinary Clini-
cal Sciences, Royal Veterinary College, University of London, North Mymms, 
Hertfordshire, UK. 
Competing interests
The authors declare that they have no competing interests.
Declaration
Publication charges for this article were funded by the research platform 
Future Animal Health and Welfare at the Swedish University of Agricultural 
Sciences.
About this supplement
This article has been published as part of Acta Veterinaria Scandinavica 
Volume 58 Supplement 1, 2016: Animal Obesity—causes, consequences and 
comparative aspects: current research. The full contents of the supplement 
are available online at http://actavetscand.biomedcentral.com/articles/
supplements/volume-58-supplement-1.
Availability of data and materials
The authors’ confirm that materials described in the manuscript will be freely 
available to any scientist wishing to use them for non-commercial purposes.
Consent for publication
The animal owner gave informed consent for publication.
Ethics approval and consent to participate
Ethics approval was not needed because all the information was obtained 
from clinical diagnosis. The animal owner gave informed consent to 
participation.
Published: 20 October 2016
References
 1. Prahl A, Guptill L, Glickman NW, Tetrick M, Glickman LT. Time trends and 
risk factors for diabetes mellitus in cats presented to veterinary teaching 
hospitals. J Feline Med Surg. 2007;9:351–8.
 2. Slingerland LI, Fazilova VV, Plantinga EA, Kooistra HS, Beynen AC. Indoor 
confinement and physical inactivity rather than the proportion of dry 
food are risk factors in the development of feline type 2 diabetes mellitus. 
Vet J. 2009;179:247–53.
 3. McCann TM, Simpson KE, Shaw DJ, Butt JA, Gunn-Moore DA. Feline dia-
betes mellitus in the UK: the prevalence within an insured cat population 
and a questionnaire-based putative risk factor analysis. J Feline Med Surg. 
2007;9:289–99.
 4. Appleton DJ, Rand JS, Sunvold GD. Insulin sensitivity decreases with 
obesity, and lean cats with low insulin sensitivity are at greatest risk of 
glucose intolerance with weight gain. J Feline Med Surg. 2001;3:211–28.
 5. Panciera DL, Thomas CB, Eicker SW, Atkins CE. Epizootiologic patterns of 
diabetes mellitus in cats: 333 cases (1980–1986). J Am Vet Med Assoc. 
1990;197:1504–8.
 6. Crenshaw KL, Peterson ME. Pretreatment clinical and laboratory evalua-
tion of cats with diabetes mellitus: 104 cases (1992–1994). J Am Vet Med 
Assoc. 1996;209:943–9.
 7. Lederer R, Rand JS, Jonsson NN, Hughes IP, Morton JM. Frequency of 
feline diabetes mellitus and breed predisposition in domestic cats in 
Australia. Vet J. 2009;179:254–8.
 8. Rand JS, Bobbermien LM, Hendrikz JK, Copland M. Over representation of 
Burmese cats with diabetes mellitus. Aust Vet J. 1997;75:402–5.
 9. Öhlund M, Fall T, Strom Holst B, Hansson-Hamlin H, Bonnett B, Egenvall A. 
Incidence of diabetes mellitus in insured Swedish cats in relation to age, 
breed and sex. J Vet Intern Med. 2015;29:1342–7.
 10. Kluger EK, Hardman C, Govendir M, Baral RM, Sullivan DR, Snow D, et al. 
Triglyceride response following an oral fat tolerance test in Burmese 
cats, other pedigree cats and domestic crossbred cats. J Feline Med Surg. 
2009;11:82–90.
 11. Lee P, Mori A, Coradini M, Mori N, Sagara F, Yamamoto I, et al. Potential 
predictive biomarkers of obesity in Burmese cats. Vet J. 2013;195:221–7.
 12. O’Leary CA, Duffy DL, Gething MA, McGuckin C, Rand JS. Investiga-
tion of Burmese cats as an inherited trait: a preliminary study. NZ Vet J. 
2013;61:354–8.
 13. Bennett N, Greco DS, Peterson ME, Kirk C, Mathes M, Fettman MJ. Com-
parison of a low carbohydrate-low fiber diet and a moderate carbohy-
drate-high fiber diet in the management of feline diabetes mellitus. J 
Feline Med Surg. 2006;8:73–84.
 14. Roomp K, Rand J. Intensive blood glucose control is safe and effective 
in diabetic cats using home monitoring and treatment with glargine. J 
Feline Med Surg. 2009;11:668–82.
 15. Roomp K, Rand J. Evaluation of detemir in diabetic cats managed 
with a protocol for intensive blood glucose control. J Feline Med Surg. 
2012;14:566–72.
 16. Sieber-Ruckstuhl NS, Kley S, Tschuor F, Zini E, Ohlerth S, Boretti FS, et al. 
Remission of diabetes mellitus in cats with diabetic ketoacidosis. J Vet 
Intern Med. 2008;22:1326–32.
 17. Marshall RD, Rand JS, Morton JM. Treatment of newly diagnosed diabetic 
cats with glargine insulin improves glycaemic control and results in 
higher probability of remission than protamine zinc and lente insulins. J 
Feline Med Surg. 2009;11:683–91.
 18. Gostelow R, Forcada Y, Graves T, Church D, Niessen S. Systematic 
review of feline diabetic remission: separating fact from opinion. Vet J. 
2014;202:208–21.
 19. Marshall RD, Rand JS, Morton JM. Glargine and protamine zinc insulin 
have a longer duration of action and result in lower mean daily glucose 
concentrations than lente insulin in healthy cats. J Vet Pharmacol Ther. 
2008;31:205–12.
 20. Gilor C, Ridge TK, Attermeier KJ, Graves TK. Pharmacodynamics of insulin 
detemir and insulin glargine assessed by an isoglycemic clamp method 
in healthy cats. J Vet Intern Med. 2010;24:870–4.
 21. Tan KC. Feline diabetes—personal experience. Diabet Med. 2003;20:80.
 22. Nack R, DeClue AE. In cats with newly diagnosed diabetes mellitus, use of 
a near-euglycemic management paradigm improves remission rate over 
a traditional paradigm. Vet Quart. 2014;34:132–6.
 23. Laflamme D. Development and validation of a body condition score 
system for cats: a clinical tool. Feline Pract. 1997;25:13–8.
 24. Niessen SJ, Powney S, Guitian J, Niessen AP, Pion PD, Shaw JA, et al. Evalu-
ation of a quality-of-life tool for cats with diabetes mellitus. J Vet Intern 
Med. 2010;24:1098–105.
 25. Michiels L, Reusch CE, Boari A, Petrie G, Mandigers P, Thollot IG, et al. 
Treatment of 46 cats with porcine lente insulin—a prospective, multicen-
tre study. J Feline Med Surg. 2008;10:439–51.
 26. Roomp K, Rand JS. Management of diabetic cats with long-acting insulin. 
Vet Clin Small Anim. 2013;43:251–66.
 27. Frank G, Anderson W, Pazak H, Hodgkins E, Ballam J, Laflamme D. Use of a 
high-protein diet in the management of feline diabetes mellitus. Vet Ther. 
2001;2:238–46.
Page 54 of 54Lewitt et al. Acta Vet Scand 2016, 58(Suppl 1):63
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 28. Coradini M, Rand JS, Morton JM, Rawlings JM. Effects of two com-
mercially available feline diets on glucose and insulin concentrations, 
insulin sensitivity and energetic efficiency of weight gain. Br J Nutr. 
2011;106(Suppl 1):S64–77.
 29. Backus RC, Cave NJ, Keisler DH. Gonadectomy and high dietary fat but 
not high dietary carbohydrate induce weight gains in body weight and 
fat of domestic cats. Br J Nutr. 2007;97:641–50.
 30. International Diabetes Federation. Position statement: self-management 
education. 2011. http://www.idf.org/education/position-statements/self-
management-education.  Accessed 20 Sep 2015.
